Verquvo cleared for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction
News
NICE recommends Incyte’s Pemazyre for rare bile duct cancer
Pemazyre recommended for the treatment of cholangiocarcinoma, a rare type of liver cancer that forms in the bile duct
Gov’t reveals new strategy to improve support and care for autistic people
The Autism Strategy will be backed by nearly £75m in the first year, which includes £40m through the NHS Long Term Plan
Orbit Discovery raises $7.6m to boost peptide drug discovery services
The latest funding round was led by Oxford Sciences Innovation
Myovant, Gedeon Richter’s uterine fibroids med Ryeqo bags EU approval
EC has cleared Ryeqo for the treatment of moderate to severe symptoms of uterine fibroids
NHS England unveils new Innovative Medicine Fund
The new fund will build upon the Cancer Drugs Fund to fast-track access to promising new treatments
Celltrion says its COVID-19 antibody shows ‘strong neutralising activity’ against Delta variant
A therapeutic dose of regdanvimab also reduced the viral load of the SARS-CoV-2 virus and inflammation in the lungs
EU approval for self-administered Crysvita
Crysvita is used to treat the rare genetic condition X-linked hypophosphataemia
Roche reveals new safety data for haemophilia treatment Hemlibra
No new safety signals identified with longer-term Hemlibra treatment in adult and adolescent patients
New advice issued on COVID-19 vaccination of children and young people
The UK’s JCVI has advised vulnerable children should be offered Pfizer/BioNTech vaccines
Reacta Biotech raises £2.9m to scale up food allergy clinical diagnostics portfolio
The latest funding round was led by Praetura Ventures with follow-on equity from the Development Bank of Wales
DSRU says more research needed to understand immunocompromised patients’ responses to COVID-19 vaccines
Studies showed immunosuppression appeared to weaken immune responses to COVID-19 vaccines
‘Most comprehensive’ flu vaccination programme in UK history launching for winter 2021
Healthcare providers will offer the flu vaccine to over 35 million people from September 2021
Ledaga recommended by NICE for rare type of lymphoma
Draft guidance recommends Ledaga for early-stage mycosis fungoides-type cutaneous T-cell lymphoma
Report finds almost 100% of people tested positive for antibodies after second vaccine dose
Over 207,337 participants tested themselves for COVID-19 antibodies at home between 12 and 25 May 2021
